Steris Stock Forecast, Price & News

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, STE stock has increased by 28.3% and is now trading at $186.42.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Steris.

Steris is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Steris.

Steris will be holding an earnings conference call on Monday, November 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Steris PLC (NYSE:STE) announced its quarterly earnings results on Monday, August, 3rd. The medical equipment provider reported $1.31 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.98 by $0.33. The medical equipment provider had revenue of $668.90 million for the quarter, compared to analyst estimates of $643.38 million. Steris had a net margin of 13.69% and a return on equity of 16.24%. The firm's quarterly revenue was down 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.23 earnings per share.
View Steris' earnings history.

Steris announced a quarterly dividend on Monday, August 3rd. Investors of record on Thursday, August 27th will be paid a dividend of $0.40 per share on Thursday, September 24th. This represents a $1.60 annualized dividend and a dividend yield of 0.86%. The ex-dividend date of this dividend is Wednesday, August 26th. This is an increase from Steris's previous quarterly dividend of $0.37.
View Steris' dividend history.

4 analysts have issued twelve-month price targets for Steris' stock. Their forecasts range from $200.00 to $200.00. On average, they anticipate Steris' share price to reach $200.00 in the next twelve months. This suggests a possible upside of 7.3% from the stock's current price.
View analysts' price targets for Steris.

Steris saw a increase in short interest in September. As of September 30th, there was short interest totaling 1,280,000 shares, an increase of 19.6% from the September 15th total of 1,070,000 shares. Based on an average daily trading volume, of 438,600 shares, the days-to-cover ratio is currently 2.9 days.
View Steris' Short Interest.

Some companies that are related to Steris include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Hologic (HOLX), Insulet (PODD), Teleflex (TFX) and Varian Medical Systems (VAR).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Steris' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.50%), Retirement Systems of Alabama (0.27%), Dearborn Partners LLC (0.24%), PGGM Investments (0.23%), Boston Trust Walden Corp (0.20%) and Fenimore Asset Management Inc. (0.12%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves, Walter M Rosebrough Jr and Walter M Rosebrough, Jr.
View institutional ownership trends for Steris.

STE stock was sold by a variety of institutional investors in the last quarter, including Denali Advisors LLC, State of Alaska Department of Revenue, Nisa Investment Advisors LLC, Xponance Inc., Copeland Capital Management LLC, MAI Capital Management, Dearborn Partners LLC, and Ellevest Inc.. Company insiders that have sold Steris company stock in the last year include Cary L Majors, Daniel A Carestio, John Adam Zangerle, Mohsen Sohi, Richard C Breeden, and Richard Martin Steeves.
View insider buying and selling activity for Steris.

STE stock was purchased by a variety of institutional investors in the last quarter, including PGGM Investments, Retirement Systems of Alabama, Envestnet Asset Management Inc., Jacobsen Capital Management, Stokes Capital Advisors LLC, Legato Capital Management LLC, Sequoia Financial Advisors LLC, and Fenimore Asset Management Inc..
View insider buying and selling activity for Steris.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of STE stock can currently be purchased for approximately $186.42.

Steris has a market capitalization of $15.86 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 13,000 workers across the globe.

The official website for Steris is www.steris.com.

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]